These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37511206)

  • 21. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
    Yesudasan S; Wang X; Averett RD
    J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
    Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
    Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 thromboinflammation: adding inflammatory fibrin to the puzzle.
    Magrini E; Garlanda C
    Trends Immunol; 2024 Oct; 45(10):721-723. PubMed ID: 39327204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of fibrinogen α
    Martinez-Torres C; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2024 Mar; 22(3):715-726. PubMed ID: 37940047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
    Pieters M; Guthold M; Nunes CM; de Lange Z
    Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients.
    De Michele M; d'Amati G; Leopizzi M; Iacobucci M; Berto I; Lorenzano S; Mazzuti L; Turriziani O; Schiavo OG; Toni D
    J Hematol Oncol; 2022 Aug; 15(1):108. PubMed ID: 35974404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring the Formation of Fibrin Clots as Part of the Coagulation Cascade Using Fluorescent Single-Walled Carbon Nanotubes.
    Gerstman E; Hendler-Neumark A; Wulf V; Bisker G
    ACS Appl Mater Interfaces; 2023 May; 15(18):21866-21876. PubMed ID: 37128896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 coagulopathy - what should we treat?
    Chowdary P
    Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?
    Kell DB; Pretorius E
    Biochem J; 2023 Aug; 480(15):1217-1240. PubMed ID: 37584410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of fibrin structure in thrombosis and vascular disease.
    Cilia La Corte AL; Philippou H; Ariëns RA
    Adv Protein Chem Struct Biol; 2011; 83():75-127. PubMed ID: 21570666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.
    de Melo GD; Lazarini F; Larrous F; Feige L; Kornobis E; Levallois S; Marchio A; Kergoat L; Hardy D; Cokelaer T; Pineau P; Lecuit M; Lledo PM; Changeux JP; Bourhy H
    EMBO Mol Med; 2021 Aug; 13(8):e14122. PubMed ID: 34170074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects.
    Boschi C; Scheim DE; Bancod A; Militello M; Bideau ML; Colson P; Fantini J; Scola B
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection.
    Boccatonda A; Campello E; Simion C; Simioni P
    Expert Rev Hematol; 2023; 16(12):1035-1048. PubMed ID: 38018136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.
    Fan BE; Ramanathan K; Sum CLL; Christopher D; Chan SSW; Lim GH; Bok CF; Wong SW; Lye DC; Young BE; Lim JY; Lee RM; Lim SP; Tan HT; Ang MK; Lau SL; Kuperan P; Ong KH; Chia YW
    J Thromb Thrombolysis; 2022 Apr; 53(3):646-662. PubMed ID: 34581945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
    Gando S; Wada T
    Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: Crocin is a promising dietary supplement candidate for COVID-19.
    Mujwar S; Sun L; Fidan O
    J Food Biochem; 2022 Sep; 46(9):e14219. PubMed ID: 35545850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.